BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
2731 – 2740 of 3090
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Suppressor Of cytokine signaling 6 (SOCS6) negatively regulates Flt3 signal transduction through direct binding to phosphorylated Tyr 591 and Tyr 919 of Flt3.
(
- Contribution to journal › Article
-
Mark
Synergistic augmentation of CD40-mediated activation of antigen-presenting cells by amphiphilic poly(γ-glutamic acid) nanoparticles.
(
- Contribution to journal › Article
-
Mark
Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation
(
- Contribution to journal › Article
-
Mark
Heavy chains of inter alpha inhibitor (IαI) inhibit the human complement system at early stages of the cascade .
(
- Contribution to journal › Article
-
Mark
Ezrin expression in rectal cancer predicts time to development of local recurrence
(
- Contribution to journal › Article
-
Mark
Myeloid malignancies with acquired trisomy 21 as the sole cytogenetic change are clinically highly variable and display a heterogeneous pattern of copy number alterations and mutations(a).
(
- Contribution to journal › Article
-
Mark
Molecular genetic characterization of the 11q13 breakpoint in a desmoplastic fibroma of bone
(
- Contribution to journal › Article
-
Mark
Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?
(
- Contribution to journal › Article
-
Mark
3,4-Diarylmaleimides-a novel class of kinase inhibitors-effectively induce apoptosis in FLT3-ITD-dependent cells
(
- Contribution to journal › Article
-
Mark
A Compartmental Model for Biokinetics and Dosimetry of 18F-Choline in Prostate Cancer Patients
(
- Contribution to journal › Article